AZ CHINOOK D3250C00059 A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
September 5, 2019
End Date
February 14, 2023
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
September 5, 2019
End Date
February 14, 2023